Systemic Inflammation Response Index (SIRI) and Monocyte-to-Lymphocyte Ratio (MLR) Are Predictors of Good Outcomes in Surgical Treatment of Periprosthetic Joint Infections of Lower Limbs: A Single-Center Retrospective Analysis

Raffaele Vitiello,Alessandro Smimmo,Elena Matteini,Giulia Micheli,Massimo Fantoni,Antonio Ziranu,Giulio Maccauro,Francesco Taccari
DOI: https://doi.org/10.3390/healthcare12090867
2024-04-24
Health Care
Abstract:Background: Periprosthetic joint infection (PJI) is a devastating complication that develops after total joint arthroplasty (TJA), whose incidence is expected to increase over the years. Traditionally, surgical treatment of PJI has been based on algorithms, where early infections are preferably treated with debridement, antibiotics, and implant retention (DAIR) and late infections with two-stage revision surgery. Two-stage revision is considered the "gold standard" for treatment of chronic prosthetic joint infection (PJI) as it enables local delivery of antibiotics, maintenance of limb-length and mobility, and easier reimplantation. Many studies have attempted to identify potential predicting factors for early diagnosis of PJI, but its management remains challenging. In this observational retrospective study, we investigated the potential role of inflammatory blood markers (neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI)) as prognostic factors in two-stage exchange arthroplasty for PJI. Methods: A single-center retrospective analysis was conducted, collecting clinical data and laboratory parameters from patients submitted to prosthetic explantation (EP) for chronic PJI. Laboratory parameters (PCR, NLR, MLR, PLR, SIRI, SII, and AISI) were evaluated at the explantation time; at 4, 6, and 8 weeks after surgery; and at reimplantation time. The correlation between laboratory parameters and surgery success was evaluated and defined as infection absence/resolution at the last follow-up. Results: A total of 57 patients with PJI were evaluated (62% males; average age 70 years, SD 12.14). Fifty-three patients with chronic PJI were included. Nine patients underwent DAIR revision surgery and chronic suppressive therapy; two patients died. Nineteen patients completed the two-stage revision process (prosthetic removal, spacer placement, and subsequent replanting). Among them, none showed signs of reinfection or persistence of infection at the last available follow-up. The other twenty-three patients did not replant due to persistent infection: among them, some (the most) underwent spacer retention; others (fewer in number) were submitted to resection arthroplasty and arthrodesis (Girdlestone technique) or chronic suppressive antibiotic therapy; the remaining were, over time, lost to follow-up. Of the patients who concluded the two-stage revision, the ones with high SIRI values (mean 3.08 SD 1.7 and p-value 0.04) and MLR values (mean 0.4 SD 0.2 and p-value 0.02) at the explantation time were associated with a higher probability of infection resolution. Moreover, higher variation in the SIRI and PCR, also defined, respectively, as delta-SIRI (mean −2.3 SD 1.8 and p-value 0.03) and delta-PCR (mean −46 SD 35.7 and p-value 0.03), were associated with favorable outcomes. Conclusions: The results of our study suggest that, in patients with PJI undergoing EP, the SIRI and MLR values and delta-SIRI and delta-PCR values could be predictive of a favorable outcome. The evaluation of these laboratory indices, especially their determination at 4 weeks after removal, could therefore help to determine which patients could be successfully replanted and to identify the best time to replant. More studies analyzing a wider cohort of patients with chronic PJI are needed to validate the promising results of this study.
health care sciences & services,health policy & services
What problem does this paper attempt to address?
### The Problem the Paper Attempts to Solve This paper attempts to solve the problem of predicting good prognosis in patients with chronic periprosthetic joint infection (PJI) undergoing two-stage revision surgery by studying inflammatory blood markers such as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic inflammation index (SII), systemic inflammation response index (SIRI), and aggregate systemic inflammation index (AISI). Specifically, the authors aim to determine which patients might be suitable for successful prosthesis reimplantation and identify the optimal reimplantation timing through these markers. ### Background and Significance 1. **Background of PJI**: - Periprosthetic joint infection (PJI) is a severe complication that typically occurs after total joint arthroplasty, with its incidence expected to increase annually. - Traditional surgical treatment for PJI is algorithm-based, with early infections typically managed by debridement, antibiotics, and implant retention (DAIR) or the more recent debridement, antibiotics beads, and implant retention (DAPRI) method, while late infections are managed by two-stage revision surgery. 2. **Limitations of Existing Research**: - Despite numerous studies attempting to identify early diagnostic factors for PJI, its management remains challenging. - Current research mainly focuses on traditional inflammatory markers such as ESR and PCR, but these markers have limited ability to predict surgical success. 3. **Research Objectives**: - This study aims to explore the potential of new inflammatory blood markers (such as SIRI and MLR) in predicting the success of two-stage revision surgery in PJI patients. - These markers could better guide clinical decision-making and improve surgical success rates. ### Methods and Results 1. **Study Design**: - This is a single-center retrospective analysis, collecting clinical data and laboratory parameters of chronic PJI patients who underwent prosthesis removal surgery from January 2020 to December 2022. - Laboratory parameters (such as PCR, NLR, MLR, PLR, SIRI, SII, and AISI) were evaluated at the time of prosthesis removal, 4 weeks post-surgery, 6 weeks post-surgery, 8 weeks post-surgery, and at the time of reimplantation. 2. **Main Findings**: - Among 57 PJI patients, 53 had chronic PJI. Of these, 19 patients completed the two-stage revision process without reinfection or persistent infection. - Patients with high SIRI values (mean 3.08, standard deviation 1.7, p-value 0.04) and high MLR values (mean 0.4, standard deviation 0.2, p-value 0.02) at the time of prosthesis removal had higher surgical success rates. - Greater changes in SIRI (mean −2.3, standard deviation 1.8, p-value 0.03) and PCR (mean −46, standard deviation 35.7, p-value 0.03) were also associated with good prognosis. ### Conclusion The study results suggest that in PJI patients undergoing prosthesis removal surgery, SIRI and MLR values and their changes (delta-SIRI and delta-PCR) may be useful indicators for predicting good prognosis. Evaluating these markers, especially at 4 weeks post-prosthesis removal, can help determine which patients might successfully undergo reimplantation and choose the optimal reimplantation timing. However, further research is needed to validate these preliminary findings.